Patrick Duriez

6.3k total citations
97 papers, 5.0k citations indexed

About

Patrick Duriez is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Patrick Duriez has authored 97 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 29 papers in Molecular Biology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Patrick Duriez's work include Lipoproteins and Cardiovascular Health (24 papers), Peroxisome Proliferator-Activated Receptors (21 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Patrick Duriez is often cited by papers focused on Lipoproteins and Cardiovascular Health (24 papers), Peroxisome Proliferator-Activated Receptors (21 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). Patrick Duriez collaborates with scholars based in France, United Kingdom and Germany. Patrick Duriez's co-authors include Jean‐Charles Fruchart, Bart Staels, Rafael Carmena, Françoise Martin‐Nizard, John J.P. Kastelein, Régis Bordet, Philippe Delerive, Christophe Furman, Giulia Chinetti and Elisabeth Teissier and has published in prestigious journals such as Circulation, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick Duriez

95 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Duriez France 34 2.1k 1.1k 993 900 875 97 5.0k
Lawrence W. Castellani United States 41 2.2k 1.1× 1.8k 1.6× 1.3k 1.3× 788 0.9× 766 0.9× 71 6.6k
Ming-Hui Zou United States 31 2.3k 1.1× 749 0.7× 616 0.6× 790 0.9× 1.3k 1.5× 38 4.8k
Yoshihiko Nishio Japan 42 1.8k 0.9× 879 0.8× 1.2k 1.2× 1.0k 1.1× 1.4k 1.6× 154 5.2k
Wing Tak Wong Hong Kong 45 1.8k 0.9× 864 0.8× 928 0.9× 1.3k 1.4× 1.3k 1.4× 156 5.3k
Bingbing Jiang United States 29 2.6k 1.3× 705 0.6× 701 0.7× 483 0.5× 1.4k 1.6× 42 4.9k
Charles L. Bisgaier United States 29 1.4k 0.7× 1.4k 1.3× 932 0.9× 423 0.5× 517 0.6× 57 4.4k
Hideaki Kaneto Japan 36 1.7k 0.8× 1.3k 1.1× 1.3k 1.4× 575 0.6× 1.1k 1.2× 106 5.3k
Christian Rask‐Madsen United States 31 1.4k 0.7× 733 0.6× 1.1k 1.1× 986 1.1× 1.3k 1.4× 55 4.5k
Shanqin Xu United States 25 2.2k 1.0× 708 0.6× 755 0.8× 449 0.5× 1.5k 1.7× 38 4.6k
Agostino Consoli Italy 47 2.4k 1.2× 1.3k 1.1× 2.3k 2.3× 829 0.9× 2.0k 2.2× 165 6.7k

Countries citing papers authored by Patrick Duriez

Since Specialization
Citations

This map shows the geographic impact of Patrick Duriez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Duriez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Duriez more than expected).

Fields of papers citing papers by Patrick Duriez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Duriez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Duriez. The network helps show where Patrick Duriez may publish in the future.

Co-authorship network of co-authors of Patrick Duriez

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Duriez. A scholar is included among the top collaborators of Patrick Duriez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Duriez. Patrick Duriez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemdani, Mohamed, Damien Cuny, Patrick Duriez, et al.. (2019). Analysis of out-of-hospital cardiac arrest and ozone pollution: A qualitative study. SHILAP Revista de lepidopterología. 6(4). 283–289. 1 indexed citations
2.
Martin‐Nizard, Françoise, Saı̈d Yous, Sébastien Dilly, et al.. (2011). Antioxydant activity of β-carboline derivatives in the LDL oxidation model. European Journal of Medicinal Chemistry. 46(6). 2575–2585. 17 indexed citations
3.
Martin‐Nizard, Françoise, Sevser Şahpaz, Bart Staels, et al.. (2008). Effects of Microdesmis keayana alkaloids on vascular parameters of erectile dysfunction. Phytotherapy Research. 23(6). 892–895. 12 indexed citations
4.
Duriez, Patrick, Régis Bordet, & Pascal Berthelot. (2007). The strange case of Dr HDL and Mr HDL: Does a NO’s story illuminate the mystery of HDL’s dark side uncovered by Dr HDL’s drug targeting CETP?. Medical Hypotheses. 69(4). 752–757. 7 indexed citations
5.
Tailleux, Anne, Gérard Torpier, Françoise Martin‐Nizard, et al.. (2005). Increased Susceptibility of Low-Density Lipoprotein to Ex Vivo Oxidation in Mice Transgenic for Human Apolipoprotein B Treated with 1 Melatonin-Related Compound Is Not Associated with Atherosclerosis Progression. Journal of Cardiovascular Pharmacology. 46(3). 241–249. 14 indexed citations
6.
Fruchart, Jean‐Charles & Patrick Duriez. (2002). HDL and triglyceride as therapeutic targets. Current Opinion in Lipidology. 13(6). 605–616. 44 indexed citations
7.
Chevé, Gwénaël, Patrick Duriez, Jean‐Charles Fruchart, et al.. (2002). Antioxidant activity of pinoline analogues in the LDL oxidation model. Medicinal Chemistry Research. 11(7). 361–379. 13 indexed citations
8.
Fruchart, Jean‐Charles & Patrick Duriez. (2002). HMG CoA reductase inhibitors and PPAR-α activators: Are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?. Current Atherosclerosis Reports. 4(6). 403–404. 3 indexed citations
9.
Glowacki, François, et al.. (2001). Evolution Pattern of Auto-Antibodies against Oxidized Low-Density Lipoproteins in Renal Transplant Recipients. ˜The œNephron journals/Nephron journals. 89(3). 303–308. 5 indexed citations
10.
Zoete, Vincent, Fabrice Bailly, Hervé Vezin, et al.. (2000). 4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 1. Antioxidant properties. Free Radical Research. 32(6). 515–524. 24 indexed citations
11.
Mackness, M., Nathalie Hennuyer, Bharti Mackness, et al.. (2000). Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits. Biochemical and Biophysical Research Communications. 269(1). 232–236. 69 indexed citations
12.
Rugeri, Lucia, Sophie Susen, Jean‐Marie Bard, et al.. (1999). Monocyte Tissue Factor Response Is Decreased in Patients with Hyperlipidemia. Thrombosis Research. 96(4). 283–292. 4 indexed citations
13.
Fruchart, Jean‐Charles, Patrick Duriez, & Bart Staels. (1999). Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Current Opinion in Lipidology. 10(3). 245–258. 359 indexed citations
14.
Duriez, Patrick & Jean‐Charles Fruchart. (1999). Recent developments in the treatment of hypertriglyceridemia. Current Atherosclerosis Reports. 1(1). 31–37. 5 indexed citations
15.
Fruchart, Jean‐Charles & Patrick Duriez. (1998). High density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie. 80(2). 167–172. 25 indexed citations
16.
Furman, Christophe, Stéphane Fouquet, Françoise Martin‐Nizard, et al.. (1998). A High Concentration of Melatonin Inhibits In Vitro LDL Peroxidation But Not Oxidized LDL Toxicity Toward Cultured Endothelial Cells. Journal of Cardiovascular Pharmacology. 32(4). 582–592. 28 indexed citations
17.
Duriez, Patrick, et al.. (1998). Post-statin approaches to hyperlipidaemia. Expert Opinion on Investigational Drugs. 7(12). 1997–2009. 1 indexed citations
18.
Bard, Jean‐Marie, G. Luc, Baptiste Jude, et al.. (1997). A therapeutic dosage (3 g/day) of borage oil supplementation has no effect on platelet aggregation in healthy volunteers. Fundamental and Clinical Pharmacology. 11(2). 143–144. 4 indexed citations
19.
Igau, Bruno, Sophie Lestavel, Véronique Clavey, et al.. (1996). Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes. Atherosclerosis. 120(1-2). 209–219. 4 indexed citations
20.
Reade, Richard, C Cachera, Patrick Duriez, et al.. (1989). Apolipoprotein B Immunochemical Heterogeneity in Dialysed Patients with Chronic Renal Failure and Patients with Coronary Artery Stenosis. American Journal of Nephrology. 9(2). 110–114. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence W. Castellani Breakdown of academic impact, for papers by Ming-Hui Zou Breakdown of academic impact, for papers by Yoshihiko Nishio Breakdown of academic impact, for papers by Wing Tak Wong Breakdown of academic impact, for papers by Bingbing Jiang Breakdown of academic impact, for papers by Charles L. Bisgaier Breakdown of academic impact, for papers by Hideaki Kaneto Breakdown of academic impact, for papers by Christian Rask‐Madsen Breakdown of academic impact, for papers by Shanqin Xu Breakdown of academic impact, for papers by Agostino Consoli
Rankless by CCL
2026